| Authors: |
Llovet JM; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. josep.llovet@mssm.edu.; Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Catalonia, Spain. josep.llovet@mssm.edu.; Institució Catalana d'Estudis Avançats (ICREA), Barcelona, Catalonia, Spain. josep.llovet@mssm.edu., Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA., Villanueva A; Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Pikarsky E; The Lautenberg Center for Immunology and Cancer Research, IMRIC, The Hebrew University of Jerusalem, Jerusalem, Israel., Roayaie S; White Plains Hospital Center for Cancer Care, Montefiore Health, White Plains, NY, USA., Lencioni R; Department of Radiology, Pisa University School of Medicine, Pisa, Italy.; Department of Radiology, Miami Cancer Insitute, Miami, FL, USA., Koike K; The University of Tokyo, Department of Gastroenterology, Tokyo, Japan., Zucman-Rossi J; Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, USPC, Université Paris Descartes, Université Paris Diderot, Paris, France.; Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France., Finn RS; Department of Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA. |
